186 related articles for article (PubMed ID: 33197439)
21. [Expression and Clinical Significance of CXCR3 in Mantle Cell Lymphoma].
Zhu MX; Wan WL; Hong Y; Zhu XW; Hu K; Wan W; Jing HM; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1831-1837. PubMed ID: 31839046
[TBL] [Abstract][Full Text] [Related]
22. An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9.
Ding Q; Xia Y; Ding S; Lu P; Sun L; Liu M
Oncotarget; 2016 Mar; 7(12):14405-14. PubMed ID: 26883105
[TBL] [Abstract][Full Text] [Related]
23. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: Relation with expression of CXC and CC chemokines on H&RS cells.
Ohshima K; Tutiya T; Yamaguchi T; Suzuki K; Suzumiya J; Kawasaki C; Haraoka S; Kikuchi M
Int J Cancer; 2002 Apr; 98(4):567-72. PubMed ID: 11920617
[TBL] [Abstract][Full Text] [Related]
24. Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma.
Lantermans HC; Minderman M; Kuil A; Kersten MJ; Pals ST; Spaargaren M
Leukemia; 2021 Mar; 35(3):881-886. PubMed ID: 32591642
[TBL] [Abstract][Full Text] [Related]
25. The CXC chemokine murine monokine induced by IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo.
Park MK; Amichay D; Love P; Wick E; Liao F; Grinberg A; Rabin RL; Zhang HH; Gebeyehu S; Wright TM; Iwasaki A; Weng Y; DeMartino JA; Elkins KL; Farber JM
J Immunol; 2002 Aug; 169(3):1433-43. PubMed ID: 12133969
[TBL] [Abstract][Full Text] [Related]
26. Sarcoidosis and the alpha chemokine MIG.
Giusti C
Clin Ter; 2020; 171(2):e161-e166. PubMed ID: 32141489
[TBL] [Abstract][Full Text] [Related]
27. [Effects of the phosphoinostitide-3'-kinase delta inhibitor, CAL-101, in combination with Bortezomib on mantle lymophma cells and exploration of its related mechanism].
Qu F; Xia B; Li X; Guo S; Zhang L; Tian C; Yu Y; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):412-7. PubMed ID: 26463142
[TBL] [Abstract][Full Text] [Related]
28. CXCR3 expression on CD34(+) hemopoietic progenitors induced by granulocyte-macrophage colony-stimulating factor: II. Signaling pathways involved.
Jinquan T; Anting L; Jacobi HH; Glue C; Jing C; Ryder LP; Madsen HO; Svejgaard A; Skov PS; Malling HJ; Poulsen LK
J Immunol; 2001 Oct; 167(8):4405-13. PubMed ID: 11591765
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
30. CXCR3-positive B cells found at elevated frequency in the peripheral blood of patients with MALT lymphoma are attracted by MIG and belong to the lymphoma clone.
Suefuji H; Ohshima K; Karube K; Kawano R; Nabeshima K; Suzumiya J; Hayabuchi N; Kikuchi M
Int J Cancer; 2005 May; 114(6):896-901. PubMed ID: 15645433
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
[TBL] [Abstract][Full Text] [Related]
32. Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+ T cells in lymphocyte-rich gastric carcinoma.
Ohtani H; Jin Z; Takegawa S; Nakayama T; Yoshie O
J Pathol; 2009 Jan; 217(1):21-31. PubMed ID: 18980207
[TBL] [Abstract][Full Text] [Related]
33. Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma.
Li XY; Geng LY; Zhou XX; Wei N; Fang XS; Li Y; Wang X
Leuk Lymphoma; 2017 Oct; 58(10):2460-2469. PubMed ID: 28278702
[TBL] [Abstract][Full Text] [Related]
34. Oral cancer-associated fibroblasts inhibit heat-induced apoptosis in Tca8113 cells through upregulated expression of Bcl-2 through the Mig/CXCR3 axis.
Bian L; Sun X; Jin K; He Y
Oncol Rep; 2012 Dec; 28(6):2063-8. PubMed ID: 22961626
[TBL] [Abstract][Full Text] [Related]
35. B7-H3 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity.
Zhang W; Wang Y; Wang J; Dong F; Zhu M; Wan W; Li H; Wu F; Yan X; Ke X
Int J Oncol; 2015; 46(6):2562-72. PubMed ID: 25872657
[TBL] [Abstract][Full Text] [Related]
36. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes.
García-López MA; Sancho D; Sánchez-Madrid F; Marazuela M
J Clin Endocrinol Metab; 2001 Oct; 86(10):5008-16. PubMed ID: 11600578
[TBL] [Abstract][Full Text] [Related]
37. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
Wu B; Li J; Wang H; Wu Q; Liu H
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
[TBL] [Abstract][Full Text] [Related]
38. Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1.
Schwarz JB; Langwieser N; Langwieser NN; Bek MJ; Seidl S; Eckstein HH; Lu B; Schömig A; Pavenstädt H; Zohlnhöfer D
Circ Res; 2009 Jan; 104(2):189-200. PubMed ID: 19059841
[TBL] [Abstract][Full Text] [Related]
39. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines.
Albanesi C; Scarponi C; Sebastiani S; Cavani A; Federici M; De Pità O; Puddu P; Girolomoni G
J Immunol; 2000 Aug; 165(3):1395-402. PubMed ID: 10903743
[TBL] [Abstract][Full Text] [Related]
40. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.
Piali L; Weber C; LaRosa G; Mackay CR; Springer TA; Clark-Lewis I; Moser B
Eur J Immunol; 1998 Mar; 28(3):961-72. PubMed ID: 9541591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
